Hiv-Tuberculous Meningitis Co-Infection: A Systematic Review and Meta-Analysis

Hiv-Tuberculous Meningitis Co-Infection: A Systematic Review and Meta-Analysis Publisher Pubmed

Purmohamad A¹ ; Azimi T^{2, 3} ; Nasiri MJ⁴ ; Goudarzi M⁴ ; Zangiabadian M¹ ; Sedighian H⁵ ; Fooladi AAI⁵

Show Affiliations

1. Student Research Committee, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2. Department of Pathobiology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
3. Students Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran
4. Department of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
5. Applied Microbiology Research Center, Systems Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran

Source: Current Pharmaceutical Biotechnology Published:2021

Abstract

Human Immunodeficiency Virus (HIV)-infected persons are at a higher risk of developing Tuberculous Meningitis (TBM). We aimed to estimate the prevalence of TBM-HIV co-infection. We systematically searched Pubmed/Medline, Embase and Cochrane library databases from January 1, 2000, to January 31, 2017, to find relevant studies. We employed the random-effects meta-analysis model to estimate the pooled prevalence of TBM-HIV co-infection. Twenty-six eligible studies showed the prevalence of HIV in TBM patients. In the pooled analyses, the prevalence of HIV was 30% (95% CI: 12-47) in patients with confirmed TBM, and 12.1% (95% CI: 7.3-19.2) in patients with suspected TBM. This study shows a high prevalence of TBM-HIV co-infection. Establishing proper diagnostic criteria and preventive measures for TBM infections could assist in the prevention and man-agement of TBM infection, particularly TBM-HIV co-infection. © 2021 Bentham Science Publishers.

Style	Citing Format
MLA	Purmohamad A, et al.. "Hiv-Tuberculous Meningitis Co-Infection: A Systematic Review and Meta-Analysis." Current Pharmaceutical Biotechnology, vol. 22, no. 7, 2021, pp. 960-968.
APA	Purmohamad A, Azimi T, Nasiri MJ, Goudarzi M, Zangiabadian M, Sedighian H, Fooladi AAI (2021). Hiv-Tuberculous Meningitis Co-Infection: A Systematic Review and Meta-Analysis. Current Pharmaceutical Biotechnology, 22(7), 960-968.
Chicago	Purmohamad A, Azimi T, Nasiri MJ, Goudarzi M, Zangiabadian M, Sedighian H, Fooladi AAI. "Hiv-Tuberculous Meningitis Co-Infection: A Systematic Review and Meta-Analysis." Current Pharmaceutical Biotechnology 22, no. 7 (2021): 960-968.
Harvard	Purmohamad A et al. (2021) 'Hiv-Tuberculous Meningitis Co-Infection: A Systematic Review and Meta-Analysis', Current Pharmaceutical Biotechnology, 22(7), pp. 960-968.
Vancouver	Purmohamad A, Azimi T, Nasiri MJ, Goudarzi M, Zangiabadian M, Sedighian H, et al.. Hiv-Tuberculous Meningitis Co-Infection: A Systematic Review and Meta-Analysis. Current Pharmaceutical Biotechnology. 2021;22(7):960-968.
BibTex	@article{ author = {Purmohamad A and Azimi T and Nasiri MJ and Goudarzi M and Zangiabadian M and Sedighian H and Fooladi AAI}, title = {Hiv-Tuberculous Meningitis Co-Infection: A Systematic Review and Meta-Analysis}, journal = {Current Pharmaceutical Biotechnology}, volume = {22}, number = {7}, pages = {960-968}, year = {2021} }
RIS	TY - JOUR AU - Purmohamad A AU - Azimi T AU - Nasiri MJ AU - Goudarzi M AU - Zangiabadian M AU - Sedighian H AU - Fooladi AAI TI - Hiv-Tuberculous Meningitis Co-Infection: A Systematic Review and Meta-Analysis JO - Current Pharmaceutical Biotechnology VL - 22 IS - 7 SP - 960 EP - 968 PY - 2021 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract